Allison Dottor, in Alburtis, PA - Occupational Therapist

Allison Dottor, is a Occupational Therapist based in Alburtis, Pennsylvania. Allison Dottor is licensed to practice in Pennsylvania (license number OC012372) and her current practice location is 3809 Gun Club Rd, Alburtis, Pennsylvania. She can be reached at her office (for appointments etc.) via phone at (610) 462-8327.

NPI number for Allison Dottor is 1902161185 and her current mailing address is 3809 Gun Club Rd, Alburtis, Pennsylvania. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1902161185.

Contact Information

	Allison Dottor,
	3809 Gun Club Rd, Alburtis, PA 18011-9557
	(610) 462-8327
	Not Available

Healthcare Provider's Profile

Full Name	Allison Dottor
Gender	Female
Speciality	Occupational Therapist
Location	3809 Gun Club Rd, Alburtis, Pennsylvania
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1902161185
Provider Enumeration Date: 07/12/2012
Last Update Date: 07/12/2012

Medical Identifiers

Medical identifiers for Allison Dottor such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1902161185	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	OC012372 (Pennsylvania)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Allison Dottor is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Allison Dottor, 3809 Gun Club Rd, Alburtis, PA 18011-9557 Ph: (610) 462-8327	Allison Dottor, 3809 Gun Club Rd, Alburtis, PA 18011-9557 Ph: (610) 462-8327

News Archive

New project could help healthcare providers plan for coronavirus consequences

Could COVID-19 harm patients after the infection has gone? Members of the EUROMENE COST Action are adapting their work on chronic fatigue syndrome to coronavirus patients.

Persons with severe symptoms of mental illness are at higher risk for being HIV-infected

People receiving mental health care are up to four times more likely to be infected with HIV than the general population, according to a new study published Feb. 13 in the American Journal of Public Health from researchers at Penn Medicine and other institutions who tested over 1,000 patients in care in Philadelphia and Baltimore.

Clinical trial to investigate safety and effectiveness of Elagolix against endometriosis

According to the Centers for Disease Control (CDC), endometriosis, a gynecological disorder in which cells from the uterus lining grow in other areas of the body, is the number one reason for a hysterectomy in women ages 18-35. Current treatment options for endometriosis are severely limited by side effects of existing medications and surgical options have more risks. A nationwide clinical trial is testing an investigational drug as a potential new option for patients with moderate to severe pain from this disease.

Novel virus-based gene therapy holds promise for Canavan disease

Research led by Paola Leone, PhD, of the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine (UMDNJ-SOM), demonstrates the long term safety and benefit of a virus-based gene therapy that has been applied for the first time in a clinical setting.

Allison Dottor, - Occupational Therapist in Alburtis, PA